Results published from the Phase 3 clinical trial showed the vaccine candidate, BNT162b2 to be 95 percent effective against COVID-19 beginning 28 days after the first dose, with all primary efficacy endpoints met.
Axios International and the National Cancer Society Malaysia (NCSM), announced a new cooperation agreement to improve patient access and adherence to treatment for oncology patients in Malaysia.
Announced in November 2020, the employee medical benefits platform, Mednefits, raised Series A funding round of SGD 8 million, led by BLoyalty Sdn Bhd, owner-operator of B Infinite.
Based on in-depth research from ADM’s proprietary consumer insights platform, the Agricultural origination and processing company, provide insights to consumer trends that will transform the food and beverage sector in 2021.
Thanyapura Sports and Health Resort, Phuket has partnered with StemCells21 (SC21), a medical biotech company based in Bangkok, Thailand, to offer premium stem cell treatments for various degenerative diseases, immune disorders, injuries and anti-ageing.
Siriraj Institute of Clinical Research and Drugs for Neglected Diseases initiative announce the signing of a memorandum of understanding to work together in conducting clinical research.
The National University Health System (NUHS) announced in October 2020 the launch of its new Centre for Innovation (CIH) as part of plan to propel Singapore’s MedTech growth as a regional hub, supporting new clinical innovation and entrepreneurial start-ups.
BioNTech and Pfizer Complete Phase 3 Study of COVID-19 Vaccine Candidate
